- Monitoring of Cardiotoxicity during Induction Chemotherapy in Acute Leukemia with Biochemical Markers2005 | First Faculty of Medicine
- Carboplatin Induction Chemotherapy in Clinically Lymph Node–positive Bladder Cancer2023 | Second Faculty of Medicine
- Radicality od surgery after inductive chemotherapy of bronchogenic cancer2000 | Central Library of Charles University, Faculty of Medicine in Pilsen
- Low molecular weight heparins for thromboprophylaxis during induction chemotherapy in patients with multiple myeloma2011 | Faculty of Medicine in Hradec Králové
- Low Molecular Weight Heparins for Thromboprophylaxis during Induction Chemotherapy in Patients with Multiple Myeloma2011 | Publication without faculty affiliation
- Monitoring of Cardiotoxicity during Induction Chemotherapy in Acute Leukemia with Biochemical Markers2005 | Faculty of Medicine in Hradec Králové
- Monitoring of Cardiotoxicity during Induction Chemotherapy in Acute Leukemia with Biochemical Markers2005 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Biochemical markers in cardiotoxicity diagnostics of induction chemotherapy in acute myeloid leukemiaPublication without faculty affiliation
- Monitoring of cardiotoxicity of induction chemotherapy in acute myeloid leukemia by biochemical markersPublication without faculty affiliation
- Monitoring of cardiotoxicity during induction chemotherapy containing idarubicin in acute myeloid leukemia with circulating markersPublication without faculty affiliation
- Risk of lung resections in patients after inductive chemotherapy of non-small cell bronchogenic cancer1999 | Faculty of Medicine in Pilsen
- Lineage switch to acute myeloid leukemia during induction chemotherapy for early T-cell precursor acute lymphoblastic leukemia with the translocation t(6;11)(q27;q23)/KMT2A-AFDN: A case report2022 | Second Faculty of Medicine
- Low levels of minimal residual disease after induction chemotherapy for BCR-ABL1-negative acute lymphoblastic leukaemia in adults are clinically relevant2022 | First Faculty of Medicine, Second Faculty of Medicine
- Treatment of High Risk Diffuse Large B-Cell Lymphomas (DLBCL) with Itensive Induction Chemotherapy, Rituximab and Autologous Stem Cell TransplantPublication without faculty affiliation
- Treatment of High Risk Diffuse Large B-Cell Lymphomas (DLBCL) with Intensive Induction Chemotherapy, Rituximab and Autologous Stem Cell Transplant.Publication without faculty affiliation
- F-18-FDG PET Response of Skeletal (Bone Marrow and Bone) Involvement After Induction Chemotherapy in Pediatric Hodgkin Lymphoma: Are Specific Response Criteria Required?2018 | Second Faculty of Medicine
- Chemotherapy versus chemoradiotherapy in borderline resectable and locally advanced pancreatic adenocarcinoma2023 | First Faculty of Medicine
- Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer2007 | Publication without faculty affiliation
- Risk factor analysis for early mortality and morbidity following pneumonectomy for non-small cell lung cancer2011 | First Faculty of Medicine
- Pneumonectomy for Non-Small Cell Lung Cancer : Predictors of Early Mortality and Morbidity2014 | First Faculty of Medicine
- Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial2017 | Second Faculty of Medicine
- Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial2019 | Publication without faculty affiliation
- Hodgkin's Lymhoma - the Treatment Aproaches Development and Current Trends2015 | First Faculty of Medicine
- The Use Biochemical Markers in Cardiotoxicity Monitoring in Patients Treated for Leukemia2005 | First Faculty of Medicine
- Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323).2010 | First Faculty of Medicine
- Maintenance treatment in non-Hodgkin´s lymphoma +12009 | Publication without faculty affiliation
- Rechallenge with anti-EGFR therapy2023 | Third Faculty of Medicine
- Childhood near-tetraploid acute lymphoblastic leukemia: an EGIL study on 36 cases2010 | First Faculty of Medicine
- Chemoresistant myeloid sarcoma responding to salvage therapy with combined azacitidine and venetoclax2022 | First Faculty of Medicine